CN116133691A - 与脂肪酸缀合的寡核苷酸 - Google Patents

与脂肪酸缀合的寡核苷酸 Download PDF

Info

Publication number
CN116133691A
CN116133691A CN202180062514.8A CN202180062514A CN116133691A CN 116133691 A CN116133691 A CN 116133691A CN 202180062514 A CN202180062514 A CN 202180062514A CN 116133691 A CN116133691 A CN 116133691A
Authority
CN
China
Prior art keywords
oligonucleotide
acid acyl
conjugated
linker
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180062514.8A
Other languages
English (en)
Chinese (zh)
Inventor
S·安德森
D·L·克纳尔
E·穆勒斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN116133691A publication Critical patent/CN116133691A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
CN202180062514.8A 2020-09-16 2021-09-15 与脂肪酸缀合的寡核苷酸 Pending CN116133691A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063079179P 2020-09-16 2020-09-16
US63/079179 2020-09-16
PCT/EP2021/075386 WO2022058386A1 (en) 2020-09-16 2021-09-15 Oligonucleotides conjugated to fatty acids

Publications (1)

Publication Number Publication Date
CN116133691A true CN116133691A (zh) 2023-05-16

Family

ID=77989771

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180062514.8A Pending CN116133691A (zh) 2020-09-16 2021-09-15 与脂肪酸缀合的寡核苷酸

Country Status (5)

Country Link
US (1) US20250270248A1 (https=)
EP (1) EP4213883A1 (https=)
JP (1) JP2023541639A (https=)
CN (1) CN116133691A (https=)
WO (1) WO2022058386A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023039522A1 (en) * 2021-09-10 2023-03-16 Guardian Therapeutics, Llc Fatty acid conjugates of nucleic acids
WO2025054459A1 (en) * 2023-09-08 2025-03-13 Dicerna Pharmaceuticals, Inc. Rnai oligonucleotide conjugates
AU2024353921A1 (en) * 2023-09-27 2026-04-16 Neuro3 Therapeutics (Suzhou) Ltd. Novel sirna constructs, therapeutics, and modifications
WO2025250382A1 (en) * 2024-05-31 2025-12-04 University Of Rochester Method and compositions for aptamer mediated delivery of therapeutics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017053995A1 (en) * 2015-09-25 2017-03-30 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
WO2019215333A1 (en) * 2018-05-11 2019-11-14 Alpha Anomeric Sas Oligonucleotides conjugates comprising 7'-5'-alpha-anomeric-bicyclic sugar nucleosides
CN110636865A (zh) * 2017-03-22 2019-12-31 加利福尼亚大学董事会 修饰的寡核苷酸及其治疗用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021046497A2 (en) * 2019-09-06 2021-03-11 Shen Haifa Orally delivered therapeutical composition and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017053995A1 (en) * 2015-09-25 2017-03-30 Ionis Pharmaceuticals, Inc. Conjugated antisense compounds and their use
CN110636865A (zh) * 2017-03-22 2019-12-31 加利福尼亚大学董事会 修饰的寡核苷酸及其治疗用途
WO2019215333A1 (en) * 2018-05-11 2019-11-14 Alpha Anomeric Sas Oligonucleotides conjugates comprising 7'-5'-alpha-anomeric-bicyclic sugar nucleosides

Also Published As

Publication number Publication date
JP2023541639A (ja) 2023-10-03
US20250270248A1 (en) 2025-08-28
WO2022058386A1 (en) 2022-03-24
EP4213883A1 (en) 2023-07-26

Similar Documents

Publication Publication Date Title
CN116133691A (zh) 与脂肪酸缀合的寡核苷酸
CN117858948A (zh) 新的治疗剂递送部分及其用途
CN103547272B (zh) 基于肽的体内siRNA递送系统
EP3144015B1 (en) Low molecular weight cationic lipids for oligonucleotide delivery
US9012225B2 (en) Lipophilic polynucleotide conjugates
EP2844662B1 (en) Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
EP3862024A1 (en) Sirna conjugate, preparation method therefor and use thereof
EP3842534A1 (en) Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof
WO2015145417A1 (en) Compounds and methods for trans-membrane delivery of molecules
JP7262816B2 (ja) ヘテロ核酸のｂｂｂ通過脂質リガンド
TW202227135A (zh) 用於遞送治療劑之脂質結合物
US20250223594A1 (en) Modified double-stranded oligonucleotide molecule, modified double-stranded oligonucleotide conjugate, and use thereof
CN116949044A (zh) 一种双链寡链核苷酸、包含该双链寡核苷酸的缀合物以及它们的用途
CN119768186A (zh) 用于向cns组织递送治疗剂的脂质缀合物
JP2023504186A (ja) 標的化された核酸送達のためのペプチドドッキング賦形剤
CN120897747A (zh) 用于递送治疗剂至脂肪组织的脂质缀合物
CN118984717A (zh) Arnatar化合物和用于增强细胞摄取的方法
RS20100249A (sr) Konjugati i postupci za njihovo dobijanje, i njihova upotreba za transport molekula kroz biološke membrane
CN114716518A (zh) 一种能够抑制pcsk9表达的分子构造及药物组合物
CN121752722A (zh) 靶向inhbe基因的双链寡核苷酸、缀合物、组合物及其用途
KR20190123351A (ko) 개질된 올리고뉴클레오티드 및 이의 치료 용도
JP2026513347A (ja) ＣＩＤＥＢ ｍＲＮＡの発現を調節するためのｄｓＲＮＡ分子
HK40094171A (zh) 与脂肪酸缀合的寡核苷酸
CN112566922A (zh) 乙酰辅酶a羧化酶2反义寡核苷酸
CN118834257A (zh) 修饰的双链寡核苷酸缀合物、组合物及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40094171

Country of ref document: HK